(NASDAQ:KTOS), SAN DIEGO, Dec. 29, 2025 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leader in defense, national security and global markets, announced today that it has recently received approximately $30 million in Air Defense and C5ISR system national-security-related, military-grade custom hardware production contracts. Kratos is an industry leader in the […]

(NYSE:INSP), MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January

(NYSE MKT:PHGE), NESS ZIONA, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that it has entered into definitive agreements in connection with a private investment in public equity (“Private Placement”) financing

neffy(R) (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis) GlobeNewswire December 29, 2025 neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix

New Crypto Mutuum Finance (MUTM) Expands Investor Base Past 18,500 While Progressing Through Roadmap Phase 2 GlobeNewswire December 29, 2025 DUBAI, United Arab Emirates, Dec. 29, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) continues to move through its published roadmap as investor participation grows and development milestones advance. The Ethereum based DeFi crypto project has

Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA GlobeNewswire December 29, 2025 Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposure FDA denial of Sanofi's tolebrutinib for nrSPMS shows need for safe therapy BOSTON, Dec. 29, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology

NIP Group Inc. Announces Results of Extraordinary General Meeting GlobeNewswire December 29, 2025 ABU DHABI, United Arab Emirates, Dec. 29, 2025 (GLOBE NEWSWIRE) — NIP Group Inc. (“NIP Group” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced that the Company's extraordinary general meeting of shareholders (the “EGM”) was held in Hong

CareCloud Appoints Chief Strategy Officer to Lead Enterprise AI Platform as Company Enters 2026 as Its Defining AI Year GlobeNewswire December 29, 2025 Strategic leadership alignment positions CareCloud to scale execution, expand margins, and accelerate AI-driven innovation across ambulatory and hospital markets SOMERSET, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) — CareCloud, Inc. (NASDAQ: CCLD, CCLDO),

MedBright AI Investments Inc. Announces Name Change and Amended Investment Policy GlobeNewswire December 29, 2025 VANCOUVER, British Columbia, Dec. 29, 2025 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (CSE: MBAI) (OTCQB: MBAIF) (FSE: Y30) (the “Company“), is pleased to announce its intention to change its name from “MedBright AI Investments Inc.” to “GoGo AI Network

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor GlobeNewswire December 29, 2025 The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential tremor Praxis remains on track to submit ulixacaltamide NDA in early 2026 based on